{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:51:44Z","timestamp":1780422704180,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,25]],"date-time":"2017-12-25T00:00:00Z","timestamp":1514160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25117719"],"award-info":[{"award-number":["JP25117719"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP16H06579"],"award-info":[{"award-number":["JP16H06579"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006091","name":"Support Center for Advanced Telecommunications Technology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005365","name":"Ehime University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16H04729"],"award-info":[{"award-number":["JP16H04729"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP15J03774"],"award-info":[{"award-number":["JP15J03774"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25290077"],"award-info":[{"award-number":["JP25290077"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.bbrc.2017.12.142","type":"journal-article","created":{"date-parts":[[2017,12,25]],"date-time":"2017-12-25T01:47:51Z","timestamp":1514166471000},"page":"2289-2295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["DANFIN functions as an inhibitor of transcription factor NF-\u03baB and potentiates the antitumor effect of bortezomib in multiple myeloma"],"prefix":"10.1016","volume":"495","author":[{"given":"Atsushi","family":"Uematsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohki","family":"Kido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6119-0034","authenticated-orcid":false,"given":"Yuuki","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Sawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2017.12.142_bib1","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrc.2017.12.142_bib2","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2017.12.142_bib3","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.hoc.2007.08.013","article-title":"Preclinical studies of novel targeted therapies","volume":"21","author":"Hideshima","year":"2007","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.bbrc.2017.12.142_bib4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fonc.2013.00120","article-title":"Targeting nuclear factor-kappaB to overcome resistance to chemotherapy","volume":"3","author":"Godwin","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2017.12.142_bib5","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1101\/gad.1228704","article-title":"Signaling to NF-\u03bab","volume":"18","author":"Hayden","year":"2004","journal-title":"Gene Dev."},{"key":"10.1016\/j.bbrc.2017.12.142_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ccr.2007.07.003","article-title":"Promiscuous mutations activate the noncanonical NF-\u03bab pathway in multiple myeloma","volume":"12","author":"Keats","year":"2007","journal-title":"Canc. Cell"},{"key":"10.1016\/j.bbrc.2017.12.142_bib7","doi-asserted-by":"crossref","first-page":"10599","DOI":"10.1073\/pnas.92.23.10599","article-title":"Stimulation-dependent I\u03baB\u03b1 phosphorylation marks the NF-\u03baB inhibitor for degradation via the ubiquitin-proteasome pathway","volume":"92","author":"Alkalay","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2017.12.142_bib8","doi-asserted-by":"crossref","first-page":"22118","DOI":"10.1074\/jbc.M601350200","article-title":"Proteasome inhibitors induces death but active NF-kappaB on endometrial carcinoma cell lines and primary culture explants","volume":"281","author":"Dolcet","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2017.12.142_bib9","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1158\/1078-0432.CCR-12-2754","article-title":"The proteasome inhibitor carfilzomib functions independently of p53 to induce cytotoxicity and an atypical NF-B response in chronic lymphocytic leukemia cells","volume":"19","author":"Gupta","year":"2013","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2017.12.142_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156718","article-title":"Establishment of a wheat cell-free synthesized protein array containing 250 human and mouse E3 ubiquitin ligases to identify novel interaction between E3 ligases and substrate proteins","volume":"11","author":"Takahashi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2017.12.142_bib11","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1016\/j.jorganchem.2006.05.020","article-title":"1,3-Diarylimidazolidin-2-ylidene (NHC) complexes of Pd(II): electronic effects on cross-coupling reactions and thermal decompositions","volume":"691","author":"T\u00fcrkmen","year":"2006","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.bbrc.2017.12.142_bib12","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/cjoc.200790291","article-title":"Electrochemical reduction of 1,2-di(p-tolylimino)ethane and 1,2-di(2,4-dimethylphenylimino)ethane in dimethylformamide","volume":"25","author":"Fotouhi","year":"2007","journal-title":"Chin. J. Chem."},{"key":"10.1016\/j.bbrc.2017.12.142_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156716","article-title":"AGIA tag system based on a high affinity rabbit monoclonal antibody against human dopamine receptor D1 for protein analysis","volume":"11","author":"Yano","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2017.12.142_bib14","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ncomms2068","article-title":"p47 negatively regulates IKK activation by inducing the lysosomal degradation of polyubiquitinated NEMO","volume":"3","author":"Shibata","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2017.12.142_bib15","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1158\/1535-7163.MCT-08-0905","article-title":"Curcumin circumvents chemoresistance in\u00a0vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model","volume":"8","author":"Sung","year":"2009","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.bbrc.2017.12.142_bib16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jmb.2010.10.055","article-title":"The RelA nuclear localization signal folds upon binding to I\u03baB\u03b1","volume":"405","author":"Cervantes","year":"2011","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.bbrc.2017.12.142_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039945","article-title":"Cross-talk between NFkB and the PI3-kinase\/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis","volume":"7","author":"Hussain","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2017.12.142_bib18","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1242\/jcs.01483","article-title":"Linking JNK signaling to NF-\u03baB: a key to survival","volume":"117","author":"Papa","year":"2004","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.bbrc.2017.12.142_bib19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2217\/14796694.3.6.639","article-title":"PI3 kinase\/AKT pathway as a therapeutic target in multiple myeloma","volume":"3","author":"Harvey","year":"2007","journal-title":"Future Oncol."},{"key":"10.1016\/j.bbrc.2017.12.142_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1182\/blood.V92.1.241.413k28_241_251","article-title":"Interleukin-6-induced inhibition of multiple myeloma cell apoptosis: support for the hypothesis that protection is mediated via inhibition of the JNK\/SAPK pathway","volume":"92","author":"Xu","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2017.12.142_bib21","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","article-title":"High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma","volume":"348","author":"Child","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2017.12.142_bib22","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1634\/theoncologist.12-6-664","article-title":"New drugs for myeloma","volume":"12","author":"Richardson","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.bbrc.2017.12.142_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.febslet.2004.06.056","article-title":"Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-\u03baB without affecting I\u03baB degradation","volume":"571","author":"Shin","year":"2004","journal-title":"FEBS Lett."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17325421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17325421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:31:56Z","timestamp":1762093916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X17325421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0006291X17325421"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.12.142","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DANFIN functions as an inhibitor of transcription factor NF-\u03baB and potentiates the antitumor effect of bortezomib in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.12.142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}